LAURIA, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 83
NA - Nord America 82
EU - Europa 42
SA - Sud America 1
Totale 208
Nazione #
US - Stati Uniti d'America 75
SG - Singapore 38
RU - Federazione Russa 23
CN - Cina 18
HK - Hong Kong 14
DE - Germania 8
TR - Turchia 6
IN - India 4
MX - Messico 4
CA - Canada 3
SE - Svezia 3
GB - Regno Unito 2
IE - Irlanda 2
IT - Italia 2
BD - Bangladesh 1
BR - Brasile 1
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
SA - Arabia Saudita 1
Totale 208
Città #
Singapore 14
Hong Kong 10
New York 7
Ashburn 6
Boardman 6
Istanbul 6
Dallas 5
Mülheim 5
Central 4
Chandler 3
Moscow 3
Ancona 2
Dublin 2
Los Angeles 2
Mexico City 2
Munich 2
San Francisco 2
Santa Clara 2
St Petersburg 2
Vancouver 2
Al Kharj 1
Augusta 1
Bento Gonçalves 1
Bremen 1
Brooklyn 1
Cambridge 1
Changsha 1
Chennai 1
Chicago 1
Chongqing 1
Cleveland 1
Denver 1
Guangzhou 1
Guiyang 1
Hounslow 1
Houston 1
Kannapolis 1
London 1
Mumbai 1
Phoenix 1
Princeton 1
Raipur 1
San Juan Bautista Tuxtla 1
Tampa 1
Tel Aviv 1
The Dalles 1
Toronto 1
Turku 1
Wilmington 1
Wuhan 1
Totale 117
Nome #
Erythropoietin both protects from and reverses experimental diabetic neuropathy 52
Erythropoietin: not just about erythropoiesis 34
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 33
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 32
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 32
Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability 31
Totale 214
Categoria #
all - tutte 2.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 3 0 0 3
2022/202329 1 1 1 1 1 3 0 1 3 11 6 0
2023/202427 1 6 2 7 2 7 0 0 0 2 0 0
2024/202584 7 4 19 0 1 5 15 9 6 9 6 3
2025/202668 11 17 21 18 1 0 0 0 0 0 0 0
Totale 214